Malaria
Approximately half of the world population lives at risk of malaria
According to the 2017 World Malaria Report, 91 countires confirmed almost 216 million cases in 2016 (an increase of 5 million compared to the previous year).
In 2016, malaria killed more than 445,000 people. Fifteen countries accounted for 80% of global deaths; all of them except one are in Subsaharan Africa, where 9 out of 10 deaths occurred.
Main Lines of Research
- Enabling technologies for malaria research
- Parasite biology
- Pathophysiology
- Malaria immunology
- Diagnostics
- Evaluation of preventive and therapeutic tools
- Epidemiology and clinical presentation of Plasmodium falciparum and Plasmodium vivax
- Vector biology and control
- Novel approaches and strategies for malaria elimination
- Health economy studies and assessment of the economic impact of malaria elimination
Our Team
Head
-
Quique Bassat Director General
Our Team
-
Azucena Bardají Associate Research Professor
-
CARLOS CHACCOUR Assistant Research Professor. BOHEMIA Co-PI and Chief Scientific Officer
-
Alfred Cortes Closas
-
Carlota Dobaño Research Professor
-
Xavier Fernàndez Busquets
-
Carmen Fernández Associate Research Professor
-
Raquel González Associated Researcher
-
Caterina Guinovart Senior Advisor for Research and Implementation on malaria elimination
-
Luis Izquierdo Lázaro Associate Research Professor
-
Alfredo Mayor Research Professor
-
Clara Menéndez Santos
-
Gemma Moncunill Assistant Research Professor
-
Hernando A. del Portillo ICREA Research Professor
-
Elisa Sicuri Associate Research Professor
-
Regina Rabinovich Director of the Malaria Elimination Initiative
Highlighted Projects
ASINTMAL
Unravelling Disease Tolerance and Host Resistance in Afebrile 'P. falciparum' Infections: a Prospective Study in Mozambican Adults
BOHEMIA
Broad One Health Endectocide-based Malaria Intervention in Africa
GenMoz
P. falciparum genomic intelligence in Mozambique
MULTIPLY
MULTIple doses of IPTi Proposal: a Lifesaving high Yield intervention
Impacto de las coinfecciones en el balance de respuestas de anticuerpos y linfocitos T helper a antígenos diana de inmunidad natural y vacunal frente a patógenos humanos prominentes
Project Code: PI20/00866
Science4Pandemics
Citizens engagement digital platform for collective intelligence in pandemics
RTS,S Vaccine Immunology Study
Study of immune correlates of protection against malaria after vaccination with RTS,S/AS01E: a comprehensive immunological arm of a Phase III double-blind, randomized, controlled multi-center trial
MESA
Sharing knowledge and catalyzing research towards a malaria-free world
Other projects
See Past ProjectsADAM
Malaria mass and focal drug administration to advance malaria elimination in Mozambique: accelerating programmatic implementation and policy translation
HIDDENVIVAX
Novel organ-on-a-chip technology to study extracellular vesicles-mediated cryptic infections in Plasmodium vivax malaria
NHEPACHA
New Tools for the Diagnosis and Evaluation of Chagas Disease
Subclinical Infections in Children and Long Term Health Effects
Infection acquisition in early life and health outcomes in childhood - MARATO TV3
EpiGen
Building Scalable Pathogen Genomic Epidemiology in Ethiopia
SMART
Identifying Severe Malaria with a new Aptamer-based Rapid diagnostic Test